Advancing cancer research and
precision medicine

Dr. Aditi Hazra from Brigham and Women’s Hospital and Harvard Medical School presents a multi-omic approach to inflammatory breast cancer (IBC) biomarker discovery.

See why Dr. Hazra believes that combining somatic mutation, copy number variation (CNV), and gene expression data will increase the probability of identifying biomarkers, especially when compared to evaluating DNA alone.

*
*
*
*
*
*

I would like to receive information about events, products, services and promotions from Thermo Fisher Scientific and its affiliates.

 By email
 By telephone

By following relevant data privacy laws, Thermo Fisher Scientific will take great care in processing your personal data in line with its privacy policy, which can be reviewed at thermofisher.com/privacypolicy.

 
 

Understand whole-transcriptome
(WT) profiling

Learn more ›

Obtain genome-wide copy number (CN)
in 48 hours

Learn more ›

Easily integrate CN and WT data 

Learn more ›